Close

Genentech (RHHBY) Announces Significant Data from TECENTRIQ Phase 3 Data in Specific Lung Cancer

Go back to Genentech (RHHBY) Announces Significant Data from TECENTRIQ Phase 3 Data in Specific Lung Cancer